Urinary micronutrient profile in different renal conditions

  • Research type

    Research Study

  • Full title

    A prospective observational study to investigate urinary micronutrient profile in patients with different renal conditions

  • IRAS ID

    207571

  • Contact name

    Mark Devonald

  • Contact email

    mark.devonald@nuh.nhs.uk

  • Sponsor organisation

    Nottingham University Hospitals NHS Trust

  • Duration of Study in the UK

    0 years, 6 months, 0 days

  • Research summary

    Acute kidney injury (AKI) is the rapid deterioration in kidney function over hours or days. It is a common problem that is associated with significant morbidity and mortality and affects approximately 10-20% of hospital admissions.

    AKI is currently identified using blood tests (creatinine levels) and urine output. Both of these are delayed markers of AKI. There is an urgent need for a reliable early test (biomarker) to allow earlier detection of AKI. In research using pigs to study AKI, we have identified that the urinary micronutrient profile (including amino acids, vitamins and trace elements) may have a role as a novel early biomarker of AKI. we are currently studying the changes in urine micronutrient profile in different groups of patients with AKI.

    It is important for us to know whether any other kidney conditions would change the micronutrient profile in the absence of AKI. This study will measure these biomarkers in patients with some of these kidney conditions: specifically urine infections (UTI), protein in the urine, chronic kidney disease, and the commonest types of kidney cancer.

    This study involves analysing urine samples from adult patients in the outpatient clinic setting (new patient renal clinics, chronic kidney disease clinics and urology cancer clinics) and during attendance for renal biopsies. We will ask volunteers to provide two urine samples at different times. It is standard practice for patients at these clinics to have blood tests.

    We will measure urinary micronutrient profile in these populations and review routine blood tests to ensure the patients qualify as a control group.

  • REC name

    London - Brent Research Ethics Committee

  • REC reference

    16/LO/1201

  • Date of REC Opinion

    30 Jun 2016

  • REC opinion

    Favourable Opinion